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Abstract The rate of thermal inactivation of Torpedo AChE at 
pH 8.5 was increased by the sullhydryl reagent 5,5’-dithiobis-(Z- 
nitrohenzoic acid) (DTNB). At 30°C or 37’C, inactivation rates 
with 0.3 mM DTNB increased about 5-fold for the wild-type 
enzyme and for two site-specific mutants, D72S and V129R. The 
reversible active site inhibitor, amhenonium, completely stabi- 
lized the wild type enzyme and partially stabilized the D72S 
mutant. However, amhenonium did not protect against the desta- 
bilization introduced by DTNB, which still accelerated inactiva- 
tion of D72S 5-fold. When the only free sulfhydryl group in AChE 
was removed by replacing cysteine 231 with serine, increased 
rates of thermal inactivation were observed. The inactivation rate 
incrased by a factor of 2 to 3 for the single mutant (C231S) and 
by a factor of 5 for the double mutant V129RK231S. Even in the 
C231S mutants, DTNB still had an additional effect. It increased 
the inactivation rate for C231S and V129RK231 by a factor of 
about 1.5 to 3 beyond the rates seen in the absence of DTNB. 
Therefore, at least part of the destabilization seen with DTNB 
in enzymes that retain C231 does not involve reaction of DTNB 
with C231. 
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1. Introduction 
Molecular modeling based on the three-dimensional struc- 
ture of acetylcholinesterase (AChE) from the electric ray Tor- 
pedo [1] has predicted a number of residues to be involved in 
the catalytic mechanism of this enzyme, and site-specific mut- 
agenesis has supported several of these predictions [24]. How- 
ever, a number of questions about the dynamic nature of the 
catalytic process and the role of a peripheral site at the surface 
of the deep active site gorge remain to be explored. It is attrac- 
tive to construct the new mutants required to investigate these 
questions in Torpedo AChE itself and thus to avoid any uncer- 
tainties introduced by computer imposition of the Torpedo 
AChE structure on the sequences of AChEs from other species. 
A problem with this approach is that Torpedo AChE is quite 
susceptible to thermal inactivation, and mammalian cells ex- 
pressing this AChE require culturing at 27°C to allow signifi- 
cant accumulation of active enzyme [5]. The problem is com- 
pounded in site-specific Torpedo AChE mutants. Many of 
these, as illustrated here with D72S and V129R, are less stable 
than the wild type enzyme. In an effort to identify specific 
residues that might be involved in the instability of Torpedo 
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AChE, we have focused on the inactivation of the enzyme by 
sulfhydryl reagents targeted to residue C231. 
The activity of Torpedo AChE has long been known to be 
sensitive to sulfhydryl alkylating reagents [6-Q. In contrast, 
AChEs from mammals or the electric eel Ekctrophorus are 
insensitive to these reagents [9-l 11. This difference in sulfhydryl 
sensitivity is consistent with known AChE sequences. All 
AChE and butyrylcholinesterase (BChE) sequences contain 
three conserved intrasubunit disulfide bonds within the cata- 
lytic subunits (see [4]) and one or two additional cysteine resi- 
dues near the C-terminus that are involved in intersubunit di- 
sulfide linkage [12-141. Torpedo AChE differs from the mam- 
malian and Electrophorus enzymes in containing one more cys- 
teine residue (C231) that is not involved in a disulfide bond in 
the assembled enzyme and that reacts with sulfhydryl alkylating 
agents [12,15]. In contrast, mammalian and Electrophorus 
AChEs do not incorporate radioalkylating agents prior to di- 
sulfide reduction [13,14,16,17]. Steinberg et al. [8] also showed 
that 5,5’-dithiobis-(2nitrobenzoic acid) (DTNB), a chromo- 
genic disulfide used to titrate the thiocholine hydrolysis product 
in the widely used assay of AChE developed by Ellman et al. 
[ 181, and other disulfide reagents can inactivate Torpedo AChE 
by reacting stoichiometrically to form a mixed disulfide that 
presumably involves C23 1 [ 191. 
din this report we examine the effects of DTNB on the 
stability of wild type and mutant Torpedo AChEs and describe 
the consequences of mutating C231 to C23lS on the enzyme 
stability. Part of the inactivating effect of DTNB remains in this 
mutant, indicating that DTNB has destabilizing effects on Tor- 
pedo AChE unrelated to mixed disulfide formation with C23 1. 
2. Materials and methods 
The pEF-Bos vector [20] expressing the H subunit of Torpedo AChE 
was mutagenized with oligonucleotide primers, and COS-7 cells were 
transfected as described [5,21]. After incubation first for 2448 h at 
37°C and then for 48 h at 27”C, the cells (10’ per dish) were washed 
and extracted at 4°C with 400 ~1 of 50 mM Tris-HCl, 40 mM MgC&, 
1% Triton X-100, and proteolysis inhibitors (0.1 mg/ml bacitracin, 25 
U/ml aprotinin, 1 mM benzamidine, 10 mM EDTA, 5 &ml pepstatin 
A, and 5 pg/ml leupeptin), and the supernatants obtained following 
centrifugation at 10,000 x g were stored at -80°C until use [5]. 
The conventional assay of AChE activity by the speectrophotometric 
procedure of Ellman et al. [ 181 was modified as follows. In Assay 1, an 
aliquot corresponding to 10 ,~l of extract containing AChE (5550 mu- 
nits) was added to 1.0 ml of pH 8.5 buffer (20 mM Tris-HCl (pH 8.5), 
0.1% Triton X-100) with or without DTNB (0.3 mM). After incubation 
for the indicated time at 37°C (unless otherwise noted), DTNB was 
added to those samples in which it had been omitted. The reaction was 
initiated by adding acetylthiocholine (10 ,ul, to a final concentration of 
0.75 mM) and measuring the change in absorbance at 412 nm for 1 mm 
on a Cary 210 spectrophotometer. To measure AChE activities in 
incubation mixtures containing AChE inhibitors, Assay 2 was intro- 
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duced to include an inhibitor dilution step. In Assay 2, an aliquot 
corresponding to 10 ,LL~ of AChE extract was mixed with inhibitor and 
pH 8.5 buffer with or without 0.3 mM DTNB (0.3 mM) in a total of 
55 ~1. After incubation for the indicated time at 37”C, 940 ,~l of 0.75 
mM acetylthiocholine and 0.3 mM DTNB in pH 8.5 buffer were added 
(the same final concentrations as in Assay 1). Rates of inactivation in 
the concentrated incubation mixture in Assay 2 were an order of mag- 
nitude lower t han those in Assay 1 even in the absence of added 
inhibitor, indicating that components in the cell extracts, probably 
Mg+*, remain high enough in concentration to exert a stabilizing effect. 
Enzyme activities are expressed in milliunits (munits), defined as 1 nmol 
of acetylthiocholine hydrolyzed per minute under the assay conditions 
and calculated from LIE,,, = 14.15 nM-’ cn-’ for thiolate dianion pro- 
duced in the assay [22]. 
Inactivation rates were calculated assuming a simple first-order inac- 
tivation of AChE activity according to Eqn. 1. 
Observed velocities v were corrected for minor background substrate 
hydrolysis ( < 5% of v,.~~J which remained after complete inactivation 
of AChE activity. 
3. Results and discussion 
The conventional Ellman assay of AChE activity utilizes 
acetylthiocholine as substrate and DTNB as the indicator of the 
thiocholine hydrolysis product. Preliminary assays of site-spe- 
cific mutants of Torpedo AChE expressed in COS cells revealed 
that some mutants were unstable in this conventional assay at 
pH 7.0 and 25°C although wild type Torpedo AChE showed 
no loss of activity. To compare the stabilities of the wild type 
and mutant AChEs, a modified assay was introduced in which 
the enzyme was preincubated in a Tris-HCl buffer (20 mM, pH 
8.5) at 37°C with or without DTNB prior to activity determina- 
tion. As shown in Fig. 1, inactivation of the wild type AChE 
was observed under these conditions, and the rate of inactiva- 
tion increased about 5-fold when DTNB was included in the 
incubation mixture (Table 1). The D72S mutant was less stable 
than wild type AChE in the absence of DTNB, and it also was 
inactivated more rapidly than the wild type when DTNB was 
present (Fig. 1 and Table 1). 
As reviewed in section 1, the increased rate of inactivation 
of wild t ype AChE in the presence of DTNB in Fig. 1 could 
indicate formation of a mixed disulfide involving C231 and 
S-thio-(2-nitrobenzoic acid). To test whether inactivation rates 
were reduced when a cationic inhibitor was bound to the AChE 
active site, incubations were conducted in the presence of am- 
benonium. This specific AChE inhibitor has high affinity for 
the human AChE active site with a competitive inhibition con- 
stant K, = 0.1 nM [23]. When 2 nM ambenonium was added to 
incubations of Torpedo AChE at pH 8.5 and 37°C the inactiva- 
tion rates of the wild type enzyme became insignificant and 
those of D72S were decreased substantially (Fig. 2 and Table 
1). Those observations are consistent with the stabilization of 
AChE by active site ligands reported previously (e.g. [16]). 
However, the inactivation rate of D72S in the presence of 0.3 
mM DTNB was still about 5 times higher than in its absence 
(Fig. 2) a difference essentially identical to that for wild type 
enzyme in the absence of ambenonium in Fig. 1. Thus am- 
benonium did not protect against the additional destabilization 
induced by DTNB, an observation that contrasts with a previ- 
ous report that the inactivation of Torpedo AChE by alkylating 
agents could be inhibited by cationic ligands bound to the 
100 
10 
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D72S: + (m) or - (0) DTNB 
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Fig. 1. Inactivation of wild type Torpedo AChE and the D72S mutant 
by incubation in pH 8.5 buffer at 37°C. Samples of wild type AChE 
with (0) or without (~3) 0.3 mM DTNB and D72S with (m) or without 
(0) 0.3 mM DTNB were incubated for the indicated times prior to 
measuring AChE activity as outlined in Assay 1 in section 2. Lines were 
calculated assuming a simple first order inactivation of AChE during 
the incubation (see eq. 1). Initial activities corresponded to 8 munit of 
wild type and 29 munit of D72S per assay. 
AChE active or peripheral sites [8]. Other active site ligands 
also can stabilize Torpedo AChE activity. For example, inacti- 
vation of wild type AChE in the absence of DTNB at 37°C was 
about four times faster in pH 7.0 sodium phosphate buffer than 
in pH 8.5 Tris-HCl buffer (data not shown), consistent with 
some AChE stabilization by cationic Tris bound to the active 
site. 
The examine directly whether the increased rates of inactiva- 
tion in the presence of DTNB in Figs. 1 and 2 could result from 
a mixed disulfide involving C23 1 and 5-thio-(2-nitrobenzoic 
acid), the site-specific mutant C23 1 S was prepared. This muta- 
Table 1 
Rates of inactivation of wild type and mutant torpedo AChEs in the 
presence and absence of DTNB 
Mutant T k- DTNB k +DTNB k +DTNB 
(“C) (min-‘) (mm’) k_,,,, 
wild type” 37 0.022 f 0.003 0.112 k 0.007 5.2 
D72S 0.164 f 0.025 > 0.5 >3 
C23lS 0.083 f 0.016 0.183 f 0.005 2.2 
wild type” 30 0.0016 + 0.0005 0.0067 f 0.0020 4.2 
C23lS 0.0029 f 0.0015 0.0086 f 0.0015 3.0 
Vl29R 0.035 2 0.010 0.154 * 0.021 4.4 
Vl29RK23lS 0.20 f 0.05 0.32 f 0.06 1.6 
Plus 2 nM ambenonium 
wild type 37 c 0.001 < 0.001 
D72S 0.0030 k 0.0005 0.0156 f 0.0014 5.2 
Inactivation rates in the absence (k-DmB) or presence (k+DTNB) were 
measured as outlined in section 2. Assay 1 was used in the absence of 
ambenonium and Assay 2, in its presence. The temperature (7) refers 
to the incubation temperature prior to assay. 
“Average of duplicate measurements. 
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tion eliminates any possibility that DTNB could form a cova- 
lent linkage with a free sulfhydryl group on Torpedo AChE. We 
found that replacement of cysteine 231 by serine increased the 
rate of thermal inactivation even in the absence of DTNB by 
a factor of 2 to 3 (Fig. 3). Addition of 0.3 mM DTNB gave a 
slight further increase in the rate of inactivation of the C231S 
mutant to a value that was comparable to that of the wild type 
enzyme in the presence of DTNB (see Table 1). Although small, 
the further destabilization of C231S by DTNB indicates that 
at least part of the destabilization of wild type enzyme by 
DTNB does not involve reaction of DNB with C23 1. 
These points were reinforced by comparison of V129R and 
V129R/C231S mutants. These mutants were too unstable for 
good quantitation at 37°C so the incubation temperatures 
were reduced to 30°C in pH 8.5 bufrer. As shown in Table 1, 
conversion of C231 to C231S in the double mutant V129RI 
C231S increased the rate of inactivation about 5-fold. DTNB 
still had a destabilizing effect on this double mutant, as in 
C231 S, increasing the inactivation rate by a factor of 1.5 rela- 
tive to the rate in the absence of DTNB. Therefore, it is again 
apparent that DTNB induces a small destabilization which 
cannot result from its reaction with the free cysteine residue. 
Destabilization of Torpedo AChE by DTNB indicates a re- 
duction in the activation energy for AChE denaturation in the 
presence of DTNB. According to classical transition state 
theory, the extent of this reduction is AGtDTNB and is given 
by Eqn. 2. 
ln(k+n&&,& = AG&wJRT (2) 
For the AChEs with C23 1 i nTable 1, the average ratio for 
k +m&m~ is about 5 and thus corresponds to a A@,,, of 
about 1.0 kcal/mole. Part of this destabilization may involve 
formation of a mixed disulfide involving C231 and 5-thio- 
wild type: + (0) or - (0) DTNB 
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Fig. 2. Ambenonium binding at the active site protects against Torpedo 
AChE inactivation but does not block the destabilization induced by 
DTNB. Samples of wild type AChE with (0) or without (0) 0.3 mM 
DTNB and D72S with (m) or without (0) 0.3 mM DTNB were incu- 
bated with 2 nM ambenonium in pH 8.5 buffer at 37°C for the indicated 
times prior to measuring AChE activity as outlined in Assay 2 in section 
2. Lines were calculated as in Fig. 1. Initial activities corresponded to 
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Fig. 3. The mutation C23lS destabilizes Torpedo AChE and partially 
but not completely eliminates further destabilization by DTNB. The 
points for wild type AChE without DTNB (I;:) were from Fig. 1. Sam- 
ples of C23 1S with (m) or without (0) 0.3 mM DTNB were incubated 
in pH 8.5 buffer at 37°C and analyzed as in Fig. 1. Initial activity 
corresponded to 16 munit of C231S per assay. 
(2-nitrobenzoic acid), but ratios of k+DTNB/k-DTNB still range 
from 1.6 to 3.0 for the C231S mutants in Table 1 and indicate 
that between 0.3 and 0.7 kcallmole of this destabilization can- 
not involve this mixed disulfide. The molecular basis of this 
additional destabilization is not clear. 
Even though the C231S mutation did not stabilize wild type 
AChE or double mutants in the presence of DTNB and actually 
destabilized them in the absence of DTNB, introduction of this 
mutation into double mutants has been observed to result in 
higher recoveries of AChE activity in transfected COS cell 
extracts (data not shown). This result may indicate that C231 
can participate in inappropriate disulfide bond formation dur- 
ing AChE folding and that the C231S mutation can eliminate 
this nonproductive pathway. 
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